We want to share the acknowledgment that APICES has received in a hereditary cancer study in the recent paper published in Hereditary Cancer in Clinical Practice journal, in which APICES has collaborated in medical writing activities. This means a…
In the challenging clinical research world, some milestones celebrate dedication and commitment. This year, APICES, a leading company in the sector, proudly commemorates its 15th anniversary. Since its inception, APICES has been an internationally renowned CRO, recognized for…
We want to share the acknowledgment that APICES has received in the EBANO in the recent paper published in ESMO Real World Data and Digital Oncology journal, in which APICES has collaborated in protocol medical writing, start-up, project management,…
APICES has received an acknowledgment in Urothelial Carcinoma in Clinical and Translational Oncology Journal
Our team at APICES CRO will be attending the ESMO Congress 2024 in Barcelona from September 13th to 17th!
Acknowledgment for APICES collaboration in RE-SERARCH study (Clinical and Translational Oncology)
This month, we want to share the acknowledgment that APICES has received in the recent publication of LOADH Study: Treatment adherence to oral chemotherapy in patients with locally advanced or metastatic small cell lung cancer: protocol for a…
This month, we want to share the acknowledgment that APICES has received in the recent publication of SPASSET Study: Healthcare Resource Utilization and Associated Costs among Patient with Advanced Non-Small-Cell Lung Cancer Receiving Chemotherapy or Immunotherapy in Spain,…
This month, we want to share the acknowledgment that APICES has received in the recent publication of HEMOLIFE Study: Humanistic burden of haemophilia Awithout inhibitors: A cross-sectional analysis of the HEMOLIFE study, published in Haemophilia in which APICES has…
